Mycobacterium leprae
Conditions
Interventions
This is an acute clinical intervention study, randomized and controlled, double blind, in which the efficacy of Photobiomodulation therapy will be tested in a population of volunteers with leprosy. F
E02.774
E02.594.540
Sponsors
Universidade Brasil
Universidade Brasil
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Clinical evidence of the disease and participation in the leprosy treatment and control program at the UBS; To be assisted at the Clínica Escola da Faculdade Guaraí; Being treated with specific multidrug therapy for Mycobacterium leprae; Age above 18 years, and in both sexes; Accepting to participate in the research through free and informed consent
Exclusion criteria
Exclusion criteria: Patients who have no records notified in the last year; Records that are erased; Cases such as diagnostic errors, even after notification; Discomfort during the application of the treatment; Cognitive impairment of understanding or important communication; Performing another treatment, other than the conventional one, for leprosy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluate and monitor the effects of LED Photobiomodulation Therapy on the cellular repair process of hypochromic and hyperchromic spots resulting from leprosy. The main outcome of this study is the tissue repair of hypo and hyperchromic stains. | — |
Secondary
| Measure | Time frame |
|---|---|
| No secondary outcomes expected. | — |
Countries
Brazil
Contacts
Public ContactClovis Henrique Souza
Universidade Brasil
Outcome results
None listed